SCG10 is a JNK target in the axonal degeneration pathway
Jung Eun Shin(Washington University in St. Louis), Aaron DiAntonio(Washington University in St. Louis), Bradley R. Miller(New York Psychoanalytic Society and Institute), Shehzad Qayum(NeuroDevelopment Center), Emilie V. Russler(NeuroDevelopment Center), Yo Sasaki(SHOWA Medical University), Yongcheol Cho(Daegu Gyeongbuk Institute of Science and Technology), Valeria Cavalli(Washington University in St. Louis), Elisabetta Babetto(The Ohio State University Wexner Medical Center), Jeffrey Milbrandt(James S. McDonnell Foundation)
Cited by 200
Related Papers
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
|Science|2004|1.1k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899